Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — December 2022

Biotek-snakken — December 2022

Planlagt Fastgjort Låst Flyttet Biotek-snakken
143 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • A Offline
    A Offline
    Aps_invest
    wrote on sidst redigeret af
    #42

    Så vendte den rundt og kører opad igen….salgsklumpen i 74 blev spist i et hug 🙂 Irriterende man ikke kan se hvem der handler mere. 😞
    14.10.52
    74,00
    4.409

    1 Reply Last reply
    0
    • D Offline
      D Offline
      DevOp
      wrote on sidst redigeret af
      #43

      Expres2ion har indgået samarbejde med Evaxion om ny CMV vaccine - fint, at de får tilføjet lidt i pipelinen https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-and-evaxion-initiate-research-collaboration-on-a-novel-cytomegalovirus--cmv--vaccine-cand,c3677859

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #44

        Godmorgen...

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #45

          Godmorgen 🙂

          1 Reply Last reply
          0
          • H Offline
            H Offline
            Hugininvest
            wrote on sidst redigeret af
            #46

            DebOp Expres2ion har såmænd sin egen chat 🙂

            1 Reply Last reply
            0
            • L Offline
              L Offline
              lahn1
              wrote on sidst redigeret af
              #47

              ZYME-ORR33% i BC https://ir.zymeworks.com/news-releases/news-release-details/new-clinical-data-zanidatamab-her2-hr-metastatic-breast-cancer-0 men overskygges af AMAMs 57% ORR og bedre DCR.Dog et meget lille studie med n=7 https://finance.yahoo.com/news/ambrx-announces-encouraging-preliminary-safety-130000477.html

              1 Reply Last reply
              0
              • L Offline
                L Offline
                lahn1
                wrote on sidst redigeret af
                #48

                Hvad siger I derude opter Jazz in på de her tal ??

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #49

                  AMAM opp med +700% og øv jeg havde glemt den selv om den stå på observationslisten. 😕

                  1 Reply Last reply
                  0
                  • F Offline
                    F Offline
                    Fandel
                    wrote on sidst redigeret af
                    #50

                    En rigtig god formiddag og weekend til jer alle...

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      DevOp
                      wrote on sidst redigeret af
                      #51

                      @Hugin: tak, det havde jeg minus opdaget 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #52

                        AbbVie Presents Data For Navitoclax Combination For JAK Inhibitor-Naïve Myelofibrosis Patients https://www.proinvestor.com/investornyt/914628/abbvie-presents-data-for-navitoclax-combination-for-jak-inhibitor-naive-myelofibrosis-patients

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #53

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #54

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #55

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #56

                                Breaking: Amgen to buy Horizon for $116.50 per share https://firstwordpharma.com/story/5685195

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #57

                                  Regeneron Pharma Announces Positive Data From Mid-stage Study Of Linvoseltamab https://www.proinvestor.com/investornyt/915039/regeneron-pharma-announces-positive-data-from-mid-stage-study-of-linvoseltamab

                                  1 Reply Last reply
                                  0
                                  • F Offline
                                    F Offline
                                    Fandel
                                    wrote on sidst redigeret af
                                    #58

                                    Godmorgen...

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      LP90
                                      wrote on sidst redigeret af
                                      #59

                                      Godmorgen 🙂

                                      1 Reply Last reply
                                      0
                                      • A Offline
                                        A Offline
                                        Aps_invest
                                        wrote on sidst redigeret af
                                        #60

                                        Health Care Direkt om XBrane…. https://www.youtube.com/watch?v=QVa4nrZf1xY

                                        1 Reply Last reply
                                        0
                                        • A Offline
                                          A Offline
                                          Aps_invest
                                          wrote on sidst redigeret af
                                          #61

                                          Ser ud som om XBrane endelig får lidt fortjent medvind 🙂 De holder jo også hvad de lover, og nærmer sig et kommercielt stadie med hastige skridt.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper